NCT06139341View on ClinicalTrials.gov

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 21, 2023

Primary Completion Date

December 17, 2023

Study Completion Date

December 17, 2023

Conditions
Healthy
Interventions
DRUG

BI 765845

BI 765845

DRUG

Placebo

Placebo

Trial Locations (1)

162-0053

Clinical Research Hospital Tokyo, Tokyo, Shinjuku-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06139341 - A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated | Biotech Hunter | Biotech Hunter